News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
NASHUA, N.H. – November 13, 2024 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months…
iCAD’s ProFound Detection Version 4.0 Gains FDA Clearance
NASHUA, N.H., November 12, 2024 — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that its ProFound Detection Version 4.0 for Digital Breast Tomosynthesis (DBT) has received clearance from the U.S. Food and Drug Administration (FDA). This next-generation…
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H. – Nov 6, 2024 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, will…
In the Media
Exploring Artificial Intelligence (AI) in Oncology
Oncology Data Advisor – Podcast
Women’s Imaging: Maximizing AI by Kathy Schilling, MD.
Radiology Today: Vol. 25 No. 5 P. 6
AI’s Arrival: Redefining Breast Cancer Detection
MD+DI, Medical Device and Diagnostic Industry
Upcoming Tradeshows & Meetings
RSNA 2024 – Radiological Society of North America Annual Meeting
Join us from December 1-5, 2024 in Chicago, IL for the RSNA 2024 – Radiological Society of North America Annual Meeting! Let’s talk about how we can help optimize your mammography workflows. Have you been following recent improvements in AI-powered early breast cancer detection?
Webinars
Symposium JFR 2024
Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris
Revue de cas cliniques avec les solutions ProFound AI détection, présentés par le Dr Rafaele Vautrin, Radiologue à Imapole Lyon Villeurbanne.
Utilisatrice de la solution ProFound IA d’iCAD pour les mammographies 2D et 3D depuis près de deux ans, le Dr Vautrin partage son retour d’expérience au travers d’une dizaine de cas cliniques pour lesquels les informations fournies par l’IA se sont avérées déterminantes pour détecter des cancers chez ses patientes.
Revolutionizing Cancer Care: The Role of AI in Breast Imaging
Hear from Dr. Nikki Gidwaney, Breast Radiologist, Stony Brook University Hospital, as she discusses how breast imaging centers are staying at the forefront with best-in-class AI solutions. She will highlight her personal journey with Breast AI solutions and the power of iCAD’s newest algorithm in helping imaging centers meet key…
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?